The formation of a functionally integrated nervous system is dependent on a highly organized sequence of events that includes timely division and differentiation of progenitors. Several apical polarity proteins have been shown to play crucial roles during neurogenesis, however, the role of Crumbs 2 (CRB2) in cortical development has not previously been reported.
Introduction
During neurogenesis, radial glial progenitor cells within the neural epithelium undergo appropriate spatiotemporal proliferation, differentiation and migration in order to produce a functionally integrated nervous system with correct lamination and intercellular synaptic connectivity (Bystron et al., 2008; Geschwind and Rakic, 2013) . Within the neuroepithelia, progenitor cells adhere to each other via subapically localized adherens junctions (AakuSaraste et al., 1996) . Neuroepithelial cells undergo interkinetic nuclear migration and the nucleus translocates to the apical surface during mitosis (Chenn and McConnell, 1995) . In contrast, intermediate progenitor cells that populate the subventricular zone (SVZ) undergo mitosis away from the ventricles. There are two migration, but without the massive cell death observed in Pals1 conditional knockout (cKO) brains (Dudok et al., 2013b) .
Furthermore, we have demonstrated that CRB2 is a novel regulator of early neural progenitors derived from mouse embryonic stem (ES) cells (Boroviak and Rashbass, 2011) . In this in vitro model, CRB2 was upregulated at the onset of neuroepithelial specification and localized to the apical side of neural rosettes. We showed that ES cells with depleted CRB2 died at the onset of neural specification. Conversely, Crb2 overexpression in undifferentiated ES cells increased proliferation and reduced terminal neural differentiation (Boroviak and Rashbass, 2011) . Recent reports showed that mutations in CRB2 cause nephrosis and cerebral ventriculomegaly in humans, suggesting alterations or defects in cortical development (Ebarasi et al., 2015; Slavotinek et al., 2015) . Amino-acid variation were detected in CRB2 but not yet linked to eye disease ( van den Hurk et al., 2005) . Mutations in human CRB1 result in Leber congenital amaurosis or retinitis pigmentosa (den Hollander et al., 1999 (den Hollander et al., , 2004 Richard et al., 2006) . CRB1 is also expressed at low levels in the developing mouse cortex (den Hollander et al., 2002) , but there are no clinical reports that mutations in human CRB1 result in cortical dysfunction.
To investigate the roles of CRB2 protein in cortical development, we used mouse models to assess the role of the CRB2 proteins during the development of the cortex. However, complete loss of CRB2 results in embryonic lethality by E12.5 (Xiao et al., 2011) . Thus, it would not be possible to use these embryos to distinguish primary neurodevelopmental defects from effects that were secondary to the earlier gastrulation abnormalities. Therefore, to address our hypothesis we analyzed the developing dorsal telencephalon of murine embryos that had Crb2 specifically ablated in this tissue on wild type genetic background as well as genetic background lacking Crb1. We demonstrate that the CRB2-depleted telencephalon undergoes premature neural differentiation and displays abnormalities in lamination. Yet, the effects observed are transient. Telencephalon lacking CRB2 resulted in disruption of apical polarity protein complexes, in partial reduced levels of adherens junction proteins, and a significant increase in cell division. As loss of CRB2 during development results in alterations in cerebral cortical development in mice, amino-acid variations in human CRB2 might be associated with cortical dysfunction in information processing or neurodevelopmental disorders.
Materials and methods
Generation of the Crb2 conditional knockout mice on wild type genetic background and background lacking Crb1
All animal procedures were performed with permission of the animal experimentation committee (DEC) of the Royal Netherlands Academy of Arts and Sciences (KNAW), permit numbers NIN06-46, NIN08-41 and NIN12.93. Crb2 floxed homozygous mice (Crb2 F/F or Crb2) and Crb1 homozygous mice on a wild type mixed genetic background (on 50% C57BL/6JOlaHsd and 50% 129/Ola) were as previously described (van de Pavert et al., 2004; Alves et al., 2013b) . The Crb2 mice (on 50% C57BL/6JOlaHsd and 50% 129/Ola) were crossed with Crb2 F/+ Emx1Cre Tg/+ (B6.129S2-Emx1tm1(cre)Krj/J +/− ; Jackson lab) mice (on 50% C57BL/6JOlaHsd and 50% 129/Ola). These mice expressed Cre recombinase under the control of Emx1 in the developing neuroepithelium of cerebral cortex and hippocampus (Gorski et al., 2002) . For homozygous Crb2 F/F Emx1Cre Tg/+ (Crb2 cKO) experimental embryos we used heterozygous Crb2 F/+ Emx1Cre Tg/+ embryos as controls. To generate Crb2 cKO mice on a background lacking Crb1 in the cortex (Crb1 −/− Crb2 F/F Emx1Cre Tg/+ in short called Crb1Crb2 cKO mice), we crossed Crb1 +/− Crb2 F/F Emx1Cre Tg/+ mice (on 50% C57BL/6JOlaHsd and 50% 129/Ola background) with Crb1 −/− Crb2 F/F (on 99.9% C57BL/6JOlaHsd background) mice to obtain control cortex expressing CRB2 on background lacking Crb1 (Crb1Crb2 control) and experimental cortex lacking CRB2 expressing CRB1 (Crb1 +/− Crb2 cKO) and cortex lacking CRB2 on background lacking Crb1 (Crb1Crb2 cKO) (all three genotypes on 75% C57BL/6JOlaHsd and 25% 129/Ola genetic background). Previously, we did not observe changes in Crb2 cKO phenotype or expression profile on mixed (50% C57BL/6JOlaHsd and 50% 129/Ola) or pure C57BL/6J genetic background (99.9% C57BL/6JOlaHsd) (Alves et al., 2013a,b) . Mice were kept on a 12 h day/night cycle plus and were supplied with food and water ad libitum. DNA isolation and genotyping was performed as described previously (van de Pavert et al., 2004; Alves et al., 2013b) . Mice had no mutations in the phosphodiesterase 6b (pde6b) or Crb1 (rd8) genes. Animal care and use in this study was in accordance with protocols and approval of the animal care and use committee of the Royal Netherlands Academy of Arts and Sciences (KNAW; protocols DEC-NIN08.41 and DEC-NIN12.93).
Immunohistochemical analysis
Timed matings were set up and the morning that the vaginal plug was discovered after mating was designated E0.5. Pregnant females were killed by CO 2 /O 2 and cervical dislocation and the embryos dissected. Embryonic heads and brains were dissected away from the bodies (which were used for genotyping). Tissue was fixed in 4% paraformaldehyde in phosphate-buffered saline (PBS) for 3 h at 4 • C and cryoprotected in 15% and 30% sucrose in PBS and then embedded in Tissue-Tek O.C.T. compound (VWR) prior to 15 m coronal cryostat sections being cut. Sections were incubated in primary antibody overnight at 4 • C solution in 0.1% Triton-X100/PBS with 5% heat inactivated donkey serum. The following primary antibodies were used: CD133 (1:250; Abcam), CRB1 (1:200) (van de Pavert et al., 2004) , CRB2 (1:250; Custom made (Boroviak and Rashbass, 2011) ), CRB3 (1:500, obtained from Dr. A. Le Bivic, Developmental Biology Institute of Marseille Luminy, Marseille, France), Cre (1:250; Covance), cleaved Caspase 3 (1:200, Cell signaling), CUX1 (1:250, Santa Cruz), Ki67 (1:100, BD Biosciences), N-cadherin (1:100; BD Biosciences), Nectin (1:500; MBL), Nestin (1:300; Abcam), PALS1 (1:200; Abcam, 1:500; Proteintech), PAR3 (1:200; Millipore), Phospho Histone H3 (pH3, 1:500; Millipore), Reelin (1:100; Millipore), SOX2 (1:250; Millipore), TBR1 (1:200; Abcam), TBR2 (1:500; Abcam), TUJ1 (1:500; Covance). Fluorescent secondary antibodies were used according to manufacturer's instructions (Jackson Immunolaboratories). DAPI (4,6-diamidino-2phenylindole, Molecular Probes) or TO-PRO3 was used to visualize nuclei (see legends of Figures). Slides were mounted in Vectashield (Vector Laboratories) or Mowiol and glass coverslips were sealed with nail varnish. Images were captured using Zeiss CLSM 510 confocal microscope or Zeiss Apotome microscope with Axioimager. Images were processed using ImageJ (NIH, http://rsb.info.nih.gov/ij), Photoshop CS4 (Adobe) and Bridge CS4 (Adobe).
BrdU injections and cell countings
For BrdU injections plugged female mice were injected peritoneally with 200 l 1 mg/ml BrdU in 0.9% NaCl and killed 30 min or 24 h after BrdU injection after which the embryos were obtained and processed as described above. For anti-BrdU immunohistochemistry, slides were incubated in PBS 0.3% Triton X-100 followed by incubation in 2 M HCl for 45 min and subsequently washed with 10 mM sodium citrate after which immunohistochemistry was performed as described above. For anti-Ki67 immunohistochemistry, antigen retrieval was first performed by boiling slides in 10 mM sodium citrate buffer after which acid treatment was performed as described above. For quantification of pH3 and BrdU cells in E12.5 cortex, cells were manually counted per 100 m cortex. Cells within 3 cell nuclei of the apical membrane where considered to be apical, whereas cells outside this region where considered basal. For the cell proliferation experiments 3 embryos/group were used for the cell countings. Statistical analysis was performed using oneway ANOVA with the Bonferroni correction. Data are shown as average ± standard error of the mean (SEM) and p < 0.05 was considered statistically significant.
Results
Cre mediated deletion results in loss of CRB2 expression in the dorsal telencephalon During cortical neurogenesis, CRB2 is expressed on the apical surface of the ventricular zone (VZ) progenitors of the dorsal telencephalon in wild type embryos ( Fig. 1) (Kim et al., 2010) . To determine whether CRB2 played a crucial role in cortical development, we examined homozygous Crb2 F/F Emx1Cre Tg/+ (Crb2 cKO) and control heterozygous Crb2 F/+ Emx1Cre Tg/+ (control) embryos on wild type background with Crb2 deleted in the cortical progenitors of the dorsal telencephalon (Gorski et al., 2002) . Control littermates showed a CRB2 expression profile during development similar to the wild type embryos ( Fig. 2A-C) . In contrast, Crb2 cKO embryos had no detectable apical CRB2 expression in the dorsal telencephalon by E12.5 ( Fig. 2A'-C') . The Crb2 cKO animals survived into adulthood and did not display any overt morphological or behavioural defects after birth (data not shown). Since in the Emx1Cre line Cre recombinase is not expressed in the ventral telencephalon, we studied the ventral expression of CRB2 in Crb2 cKO embryos. This revealed that in control cortex, the level and localization of CRB2 is comparable between dorsal and ventral telencephalon ( Fig. 2D and E) . In contrast, in Crb2 cKO embryos there is a clear loss of CRB2 from the dorsal telencephalon, whereas levels and localization of CRB2 in the ventral telencephalon is comparable to control embryos ( Fig. 2D' and E' ). This shows that there In the ventral telencephalon of control cortex level and localization of CRB2 is comparable between dorsal and ventral telencephalon ( Fig. 2D and E). In contrast, in Crb2 Emx1Cre cKO embryos, in which Cre is expressed in the dorsal, but not the ventral, telencephalon, there is a clear loss of CRB2 from the dorsal telencephalon, whereas levels and localization of CRB2 in the ventral telencephalon is comparable to control embryos ( Fig. 2D ' and E'). Nuclei counterstained with DAPI or TO-PRO3 (blue). Scale bars: 20 m. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.) is a specific loss of CRB2 from the dorsal telencephalon in Emx1Cre Crb2 cKO embryos.
Loss of CRB2 affects the neural progenitor cell population
To investigate the consequences of loss of CRB2 in cortical progenitor cells, the expression profile of SOX2 (Bylund et al., 2003) , Nestin (Lendahl et al., 1990) , Prominin (Marzesco et al., 2005) and TBR2 (Sessa et al., 2008) was analyzed in both control Crb2 F/+ Emx1Cre Tg/+ and Crb2 cKO littermates. At E12.5, SOX2 positive progenitors with clear nuclear staining were observed in the VZ of the control telencephalon (Fig. 3A) . In contrast very few cells in the Crb2 cKO cortex showed distinct nuclear localization of SOX2 (Fig. 3A' ). At E14.5 the staining for SOX2 in the Crb2 cKO dorsal telencephalon did not appear to be different from the controls. (Fig. 3B, B' ). At E17.5 the control telencephalon had some SOX2 positive cells lining the ventricles however the majority was dispersed within the SVZ (Fig. 3C ). In contrast, at this stage there were no SOX2 positive cells detected in the dorsal telencephalon of Crb2 cKO mutants although SOX2 positive cells were still present in the lateral region (Fig. 3C') .
Expression of Prominin (CD-133) an apical neuroepithelial stem cell marker (Marzesco et al., 2005) was completely lost in the Crb2 cKO dorsal telencephalon at E14.5 whilst it was still present in the controls (Fig. 3D, D' ). Nestin staining was also disturbed in the mutant cortex, so that its expression was markedly reduced at E12.5 compared to the control littermates ( Fig. 3E , E'). At E14.5 the Nestin positive fibres were disorganized and significantly reduced in the mutant telencephalon compared to the controls (Fig. 3F, F' ). By E17.5, Nestin expression was specifically restricted to a population of cells close to the ventricle in the control (Fig. 3G ). In contrast, Nestin expression was completely downregulated in the mutant (Fig. 3G') .
Combined the SOX2, Prominin and Nestin data implied that there were significant alterations in the apical neural progenitor population in the mutant. Therefore, the expression pattern of TBR2 was analyzed to determine whether the intermediate progenitor population was also affected. At E12.5, TBR2 was expressed in the SVZ of the control cortex (Fig. 3H) . Interestingly, in the Crb2 cKO cortex TBR2 positive cells were detected not only in the SVZ but also within the VZ (Fig. 3H') . Taken together these results indicate that conditional deletion of CRB2 from the cortex leads to a depletion of the apical neural progenitor pool and a concomitant increase in the basal progenitor pool.
Analysis of Crb2 cKO cortex on genetic background lacking Crb1
Previously, we have generated Crb1 KO and Crb2Chx10Cre cKO, Crb2CrxCre and Crb2PdgfraCre mice (van de Pavert et al., 2004; Alves et al., 2013b Alves et al., , 2014 and analyzed Crb2Chx10Cre cKO retinas on genetic background lacking Crb1 (Pellissier et al., 2013) . As removal of CRB2 in the developing cortex resulted in a clear phenotype in the developing cortex in embryos but no detectable morphological phenotype in newborn pups, we analyzed Crb2 cKO cortex on genetic background lacking Crb1 (Crb1Crb2 cKO, expressing Cre recombinase), and as control homozygous Crb2 F/F floxed cortex on genetic background lacking Crb1 (Crb1Crb2 control, not expressing Cre recombinase). Although CRB1 is predominantly expressed in the developing retina, in the developing cortex there are low levels of Crb1 transcripts (den Hollander et al., 2002) . Therefore, we aimed to investigate whether Crb2 cKO cortex on genetic background lacking Crb1 result in a more severe cortical phenotype than on wild type background. Immunohistochemistry for CRB2 in the developing cortex at E12.5 and E14.5 showed expression of CRB2 at the apical membrane in cortex expressing CRB2 (Crb1Crb2 control; Fig 
CRB2 is required for maintenance of the apical complex proteins
To investigate the effect that Crb2 deletion had on the expression of apical polarity components, the expression of two proteins -PALS1, a member of the Crumbs complex, and PAR3, a member of the PAR complex, were analyzed. In the control littermate embryos on wild type genetic background, PALS1 was expressed in the apical domain of the VZ cells at E12.5 and E14.5 ( Fig. 4E and F) in a similar manner as that described by others (Kim et al., 2010) . In contrast, in the Crb2 cKO embryos on wild type genetic background, the expression of PALS1 was barely detectable at both these stages ( enriched at the apical surface of the VZ progenitors in the control embryos at E12.5 and E14.5 ( Fig. 4G and H) . Similar to PALS1 expression, the expression of PAR3 at the apical membrane was also reduced in the Crb2 cKO cortex at E12.5 (Fig. 4G') . Whereas there was a difference for PAR3 staining at E12.5 in the Crb2 cKO cortex, at E14.5 there was no detectable difference (Fig. 4H') . Next, we analyzed the expression of apical complex proteins in the Crb2 cKO cortex on genetic background lacking Crb1. CRB3 is expressed at the apical membrane in the wild type cortex (Srinivasan et al., 2008) . At E12.5, CRB3 was apically localized in cortex expressing CRB2 lacking Crb1 (Crb1Crb2 control; Fig. 4I ), with higher levels of CRB3 at the apical membrane at E14.5 (Fig. 4J) . Cortex lacking CRB2 on background lacking Crb1 (Crb1Crb2 cKO) or cortex lacking CRB2 expressing CRB1 (Crb1 +/− Crb2 cKO) showed reduced levels of apical CRB3 at E12.5 and E14.5 (Fig. 4I'-J") . Next, we investigated the localization of PALS1 at the apical cortical membrane. At E12.5, similar as CRB3, PALS1 was apically localized in cortex expressing CRB2 lacking Crb1 (Crb1Crb2 control; Fig. 4I and J) . Cortex lacking CRB2 on background lacking Crb1 (Crb1Crb2 cKO) or cortex lacking CRB2 expressing CRB1 (Crb1 +/− Crb2 cKO) showed reduced levels of apical PALS1 at E12.5 and E14.5 (Fig. 4K'-L") . These data strongly suggest that CRB2 is required for the maintenance of apical polarity proteins such as PALS1, CRB3 and PAR3.
CRB2 is required for maintenance of adherens junctions
To determine if loss of Crb2 also has an effect on localization of junction-associated proteins, the expression pattern of N-cadherin (Kadowaki et al., 2007) and ZO-1 (Aaku-Saraste et al., 1996) were analyzed. At E12.5, N-cadherin expression was enriched in the apical domain of the VZ progenitors of control embryos on wild type genetic background (Fig. 5A) . However, in the Crb2 cKO dorsal telencephalon at wild type genetic background, the apical expression of N-cadherin was perturbed and instead N-cadherin was expressed in a diffuse manner within the VZ as well as weakly within the SVZ (Fig. 5A') . At E14.5, N-cadherin was still detected at the apical surface and within the SVZ of control embryos (Fig. 5B) . However, by this stage there was no N-cadherin expression within the Crb2 cKO dorsal telencephalon (Fig. 5B') . In contrast to the reduced levels of N-cadherin at the apical region, ZO-1 appeared more restricted at the apical region in the Crb2 cKO telencephalon (Fig. 5C, C' ). These data imply that the junctional proteins N-cadherin and ZO-1 require apical CRB2 expression for correct localization.
Next, we examined the Crb2 cKO telencephalon on genetic background lacking Crb1. Immunohistochemistry for the adherens junction protein ␤-catenin showed that at E12.5, cortex lacking CRB2 on background lacking Crb1 (Crb1Crb2 cKO) or cortex lacking CRB2 expressing CRB1 (Crb1 +/− Crb2 cKO) showed no obvious differences in levels of ␤-catenin compared to cortex expressing CRB2 lacking Crb1 (Crb1Crb2 control; Fig. 5D-D" ), but ␤-catenin localization seemed to be partially redistributed more basally in the cortex lacking CRB2. In contrast, at E14.5 there was a partial reduction and redistribution of ␤-catenin in cortex lacking CRB2 expressing CRB1 (Crb1 +/− Crb2 cKO) compared to cortex expressing CRB2 on background lacking Crb1 (Crb1Crb2 control; Fig. 5E , E'), and a prominent decrease and partial redistribution in ␤-catenin levels in the cortex lacking CRB2 on background lacking Crb1 (Crb1Crb2 cKO; Fig. 5E") .
We observed an expression pattern similar to ␤-catenin for the adherens junction protein p120 catenin. At E12.5, there is no difference in the level and localization of p120 catenin in telencephalon lacking CRB2 on background lacking Crb1 (Crb1Crb2 cKO) or cortex lacking CRB2 expressing CRB1 (Crb1 +/− Crb2 cKO) compared to telencephalon expressing CRB2 on background lacking Crb1 (Crb1Crb2 control; Fig. 5F-F") . In contrast, in E14.5 cortex there is a dramatic reduction in the apical expression of p120 catenin in cortex lacking CRB2 on background lacking Crb1 (Crb1Crb2 cKO; Fig. 5G ") compared to cortex expressing CRB2 on background lacking Crb1 (Crb1Crb2 control) and cortex lacking CRB2 expressing CRB1 (Crb1 +/− Crb2 cKO; Fig. 5G-G' ). The transmembrane adherens junction protein Nectin1 showed no difference between the different cortices (Fig. 5H-H") . Overall, the data shows that loss of Crb2 affects apical localization of adherens junction proteins N-cadherin, ␤-catenin and ZO-1, whereas the apical localization of Nectin1 was unaffected.
CRB2 is required for restricting cell division in the ventricular zone
To determine if loss of apical CRB2 expression influenced the location of mitotic cells, the expression profile of pH3 (phosphorylated Histone H3) a late G2/mitotic phase marker was analyzed. In control cortex expressing CRB2 on background lacking Crb1 (Crb1Crb2 control), the majority of pH3 + mitotic cells are localized at the apical membrane, whereas only a minor proportion of mitotic cells have a more basal localization ( Fig. 6A and D ; total 5.86 ± 0.17, apical 5.09 ± 0.15, basal 0.77 ± 0.07 pH3 + cells/100 m cortex, n = 3 embryos/group, 4-10 images/embryo). Quantification of mitotic cells in cortex lacking CRB2 expressing CRB1 (Crb1 +/− Crb2 cKO) revealed that the total number of mitotic cells is increased compared to control, due to increased number of apically localized mitotic cells, whereas the number of basally localized mitotic cells was not different ( Fig. 6B and D ; total 7.34 ± 0.26, apical 6.25 ± 0.23 (p < 0.01), basal 1.09 ± 0.11 pH3 + cells/100 m cortex, n = 3 embryos/group, 4-10 images/embryo). Interestingly, in cortex lacking CRB2 on background lacking Crb1 (Crb1Crb2 cKO) the number of mitotic cells is increased even further, and the number of basally localized mitotic cells is significantly increased ( Fig. 6C and D; total 9 .31 ± 0.29, apical 7.65 ± 0.23 (p < 0.0001), basal 1.66 ± 0.15 (p < 0.05) pH3 + cells/100 m cortex, n = 3 embryos/group, 4-10 images/embryo).
In the retina, loss of both Crb1 and Crb2 results in increased cell proliferation (Pellissier et al., 2013) . Therefore, to investigate whether Crb2 cKO cortex on a background lacking Crb1 affect cell proliferation, we performed BrdU injections in pregnant female mice to determine the rate of cell division in embryonic cortices. Thirty minutes of BrdU exposure in E12.5 embryos showed that cortex lacking both CRB2 and CRB1 (Crb1Crb2 cKO) and cortex lacking CRB2 expressing CRB1 (Crb1 +/− Crb2 cKO) displayed an increased rate of cell division compared to control cortex expressing CRB2 on background lacking Crb1 (Crb1Crb2 control; Fig. 6A -C, E; Crb1Crb2 control 58.2 ± 1.1, Crb1 +/− Crb2 cKO 88.9 ± 2.7, Crb1Crb2 cKO 88.3 ± 2.3 BrdU + cells/100 m cortex, n = 3 embryos/group, 3-4 images/embryo, p < 0.05).
Surprisingly, although we found increased cell division in E12.5 cortex lacking CRB2 on background lacking Crb1 (Crb1Crb2 cKO), we did not observe an increase in cortical thickness (data not shown). We reasoned that this could be attributed to increased apoptosis or an increase in the percentage of cells exiting the cell cycle. First, we investigated the possibility of increased apoptosis in the mutant cortex by performing immunohistochemistry for the marker for apoptosis cleaved Caspase 3 (cCaspase3). Although at E12.5 and E14.5 we found sporadic apoptosis in both cortex lacking CRB2 expressing CRB1 (Crb1 +/− Crb2 cKO) and cortex lacking CRB2 on background lacking Crb1 (Crb1Crb2 cKO) cortex, the cell death could clearly not compensate for the increased cell division observed in the mutant cortex (Fig. 6F, G and data not shown) .
Therefore, next we determined percentage of cells exiting the cell cycle after a 24 h BrdU exposure in E13.5 embryos. We performed immunohistochemistry for BrdU and Ki67 and quantified the number of BrdU + /Ki67 − cells compared to the total number of BrdU + cells, which represents the population of cells that have exited the cell cycle. This revealed that the number of BrdU + cells is not different (Fig. 6H-K ; Crb1Crb2 control 141.7 ± 5.3, Crb1 +/− Crb2 cKO 136.8 ± 9.9, Crb1Crb2 cKO 142.3 ± 3.4 BrdU + cells/100 m cortex, n = 2-3 embryos/group, 2-4 images/embryo). However, Crb2 cKO cortex and Crb2 cKO cortex lacking Crb1 showed an increased number of progenitor cells exiting the cell cycle (Fig. 6H -J, L; Crb1Crb2 control 2.20 ± 0.24%, Crb1 +/− Crb2 cKO 4.99 ± 0.63%, Crb1Crb2 cKO 5.52 ± 0.42%, (p < 0.001) n = 2-3 embryos/group, 2-4 images/embryo).
Additionally, to further explore whether the increased cell division is observed throughout the development of the cortex, or is only transient, we quantified mitotic cells in E14.5 cortex. This showed that the number of mitotic cells, both apically as well as basally localized mitotic cells, is not significantly different, strongly suggesting that the increased cell division we observed at E12.5 is only a transient effect in Crb2 cKO cortex lacking Crb1 ( Fig. 6M-P ; Crb1Crb2 control total 4.32 ± 0.23, apical 3.71 ± 0.21, basal 0.61 ± 0.12; Crb1 +/− Crb2 cKO total 4.44 ± 0.2, apical 3.93 ± 0.18, basal 0.51 ± 0.09; Crb1Crb2 cKO total 5.32 ± 0.48, apical 4.03 ± 0.3, basal 1.29 ± 0.23 pH3 + cells/100 m cortex, n = 2 embryos/group, 2-7 images/embryo). Thus, although at E12.5 loss of CRB1 and CRB2 results in increased progenitor cell proliferation in the cortex, this effect is only transient and is compensated for by increased exit from the cell cycle.
Loss of CRB2 causes precocious neural differentiation and mild abnormalities in cortical lamination
In order to determine whether loss of CRB2 affected terminal neural differentiation, expression of TUJ1 and TBR1, markers for (early) post-mitotic neurons, was analyzed. At E12.5 there was no significant alteration in the early neural protein TUJ1 in the Crb2 cKO cortex compared to the Crb2 F/+ Emx1Cre Tg/+ control cortex (Fig. 7A, A' ). However, at E14.5 there seemed to be an expansion of the TUJ1 positive neuronal domain in the Crb2 cKO cortex compared to the control (Fig. 7B, B' ). Furthermore, mislocalised TUJ1 positive neurons were also observed in the VZ of the mutant telencephalon (Fig. 7B') . By E17.5, there was a notable increase in TUJ1 positive neurons in all layers of the cortex in both control and mutant littermates (Fig. 7C, C' ).
To further investigate the lamination and spatial pattern of neural differentiation in the Crb2 cKO brains, the expression of two cortical neuronal proteins, TBR1 a marker for post-mitotic neurons (Bulfone et al., 1995) and Reelin which marks Cajal-Retzius cells in the superficial marginal zone of the cortical plate (D'Arcangelo et al., 1995) , were analyzed. At E14.5 there was no significant difference in TBR1 expression profile between Crb2 cKO mutants and their control littermates (Fig. 7D, D' ). At E17.5, TBR1 was expressed in the upper layers of the cortex and in the subplate of the control cortex (Fig. 7E ). In the Crb2 cKO cortex, TBR1 expressing cells were detected in the same regions as in the controls (Fig. 7E') . However, a few TBR1 positive cells were also detected outside their normal expression domain (Fig. 7E') . At the same stage, the Reelin positive cells were expressed in a compact laminar pattern in the controls (Fig. 7F) . In contrast, in the Crb2 cKO dorsal telencephalon, Reelin labelled cells were detected in a disorganized fashion at the marginal zone (Fig. 7F') .
In the retina, loss of Crb1 and Crb2 results in an increase in retinal thickness, a clear disruption of layering integrity followed by massive retinal disorganization and eventually retinal degeneration (Pellissier et al., 2013) . To investigate whether in the cortex a similar phenotype occurred, and whether loss of both CRB1 and CRB2 results in a more dramatic lamination defect than loss of CRB2 only, we first investigated the pattern of TUJ1 positive neurons. This revealed that similar to Crb2 cKO (see Fig. 7A -C'), both in cortex lacking CRB2 expressing CRB1 (Crb1 +/− Crb2 cKO) and in cortex lacking CRB2 on background lacking Crb1 (Crb1Crb2 cKO) the area occupied by TUJ1 + cells seems to be increased, with no difference between cortex lacking CRB2 expressing or lacking Crb1 (Fig. 7G-G") . Next, we analyzed the localization of TBR1 + neurons in the different cortices. Similar to the phenotype observed in Crb2 cKO cortex, at E14.5 the pattern of TBR1 + neurons seemed to be not different between cortex expressing CRB2 on background lacking Crb1 (Crb1Crb2 control) and cortex lacking CRB2 expressing CRB1 (Crb1 +/− Crb2 cKO) and cortex lacking CRB2 on background lacking Crb1 (Crb1Crb2 cKO) (Fig. 7H-H") . Finally, we investigated whether gross overall architecture of the cortex would be affected in Crb2 cKO cortex lacking Crb1. To this end we performed nuclear staining on E18.5 cortex. This showed that loss of CRB2 and/or CRB1 seems to not affect late stage cortical layering (Fig. 7I-I") . Furthermore, the distribution of the late-born CUX1 + neurons is not affected by the removal of CRB2 and/or CRB1 (Fig. 7J-J") . Overall, these results indicate that in the absence of CRB2 there is premature and mislocalized differentiation of neurons and subtle abnormalities in cortical lamination although gross cortical morphology is unaffected. However, this phenotype is not exacerbated in Crb2 cKO lacking Crb1 compared to Crb2 cKO on wild type genetic background.
Discussion
Recent reports showed that mutations in human CRB2 cause nephrosis and cerebral ventriculomegaly in humans, suggesting alterations or defects in cortical development (Ebarasi et al., 2015; Slavotinek et al., 2015) . To investigate the functional requirement of CRB2 in mice we used Emx1Cre to specifically ablate Crb2 in the dorsal telencephalon. We studied the loss of CRB2 on a wild type genetic background as well as loss of CRB2 on genetic background lacking Crb1. Our results indicate that CRB2 plays an important role in recruiting other proteins to the apical and junctional domain. Furthermore, absence of CRB2 results in premature neural differentiation and abnormal lamination indicating that Crb2 does play a role in cortical neural development. Additionally, to investigate whether there could be functional redundancy between CRB2 and other Crumbs proteins, we made mutant mice lacking both Crb1 and Crb2 in the dorsal telencephalon. In these cortices, levels of PALS1 and CRB3 at the apical membrane are reduced and progenitor cell division increased at E12.5 and E14.5, but the overall lamination of the cortex is grossly unaffected from E18.5.
Crb2 cKO cortex and Crb2 cKO cortex lacking Crb1 showed decreased expression of polarity proteins of the Crumbs and PAR complexes. Removal of CRB2 results in reduced levels of both PALS1 and CRB3. Removal of CRB2 on genetic background lacking Crb1 results in further reduction of adherens junctions proteins N-cadherin, ß-catenin, p120. It has been shown previously that PALS1 is an intracellular binding partner of CRB2 (Kim et al., 2010) ; therefore, the reduced levels of PALS1 expression in the Crb2 cKO cortex was not unexpected. Conditional removal of Pals1 leads to premature neural differentiation, massive apoptosis of precocious neurons and subsequently ablation of the entire neocortex (Kim et al., 2010) . Intriguingly, the massive cell death phenotype observed in Emx1Cre Pals1 cKO embryos (Kim et al., 2010) was not observed in Crb2 cKO on wild type genetic background or Crb2 cKO cortex lacking Crb1 despite the absence of apically enriched PALS1. Recently it was shown that conditional ablation of MPP3, an interacting partner of PALS1 affects apical expression of PALS1 but does not mimic the gross death phenotype observed in Pals1 cKO mice (Dudok et al., 2013a,b) . It is plausible that the timing of Pals1 ablation, together with its effect on interacting proteins influences cell survival and that this temporal sequence of events is different between the Pals1 cKO and Crb2 cKO and Crb2 cKO lacking Crb1 embryos. The reduced levels of PAR3 expression after CRB2 deletion is in agreement with previous studies in mammalian epithelial cell lines that have reported a direct interaction between the Crumbs and PAR complexes (Hurd et al., 2003) . Surprisingly, apical expression of PAR3 was restored in the Crb2 cKO cortex by E14.5. It is therefore possible that two separate mechanisms regulate PAR3 localization at different stages of neural development: the earlier mechanism is CRB2 dependent whilst at later stages a CRB2 independent mechanism is in place. Alternatively, progenitors at different developmental stages may have different requirements for setting up polarity protein complexes. An in depth understanding of the context-dependent dynamics of cell polarity pathways in the manifestation of neural progenitor polarity will help determine how polarity proteins effect specialized and diverse functions during neocortical development.
Given the important roles for polarity proteins during neural development, it is highly plausible that the switch in cell fate to generate intermediate progenitors/neurons instead of maintaining an apical progenitor-state in the Crb2 cKO cortex may stem from the disruption of the apical domain. The absence of apical components may lead to inadequate tethering of the cells to the VZ, thereby, exposing these cells to different extrinsic cues and subsequently affecting their fate. It has been reported that intact cell junctions are a fundamental prerequisite for normal neural progenitor cell proliferation in Drosophila (Lu et al., 2001) . However, the presence of intact apical junctions is not an absolute requirement in regulation of vertebrate neurogenesis. For instance, conditional knockout of aPKC disrupted adherens junctions yet failed to have an impact on neurogenesis (Imai et al., 2006) . Conversely, in MALS triple knockout mutant embryos, adherens junctions were unaffected but significant defects in proliferation of neural progenitors were observed (Srinivasan et al., 2008) . Taken together, this suggests that the Crb2 cKO phenotype cannot be solely attributed to loss of apical junctional components.
Mislocalization of Reelin and TBR1 positive cells in the absence of CRB2 suggests that secondary to defects in cell polarity, lamination is also mildly affected in the mutant developing cortex. Reelin is crucial for the inside-out layering of the cortex (Caviness, 1982) and mislocalization of Reelin positive cells in the Crb2 cKO cortex could in turn affect the precise localization of layer-specific neurons in the cortex. One possible explanation is that absence of apical CRB2 expression renders cells unable to respond appropriately to extrinsic guidance cues and subsequently affects their spatial localization.
One key question that needs to be addressed is how CRB2 links signalling events during neurogenesis to regulate neuronal output. Crumbs is the only known apical polarity protein to have an extracellular domain and therefore it is tempting to speculate that it is an ideal candidate for the transduction of signals originating at the luminal surface to the neural progenitor cells. The Notch signalling cascade is essential for maintenance of progenitor pools and in the control of neurogenesis in the developing and adult brain. Inactivation of Notch signalling results in depletion of the progenitor population and induces precocious neural differentiation. On the other hand, activation of Notch signalling keeps the neural stem cells in a progenitor state and thereby maintains the progenitor pool (Bertrand et al., 2002; Kageyama et al., 2008; Kopan and Ilagan, 2009) . A potential interaction between Crumbs and Notch was initially reported in Drosophila (Herranz et al., 2006) . Recently it was reported that in zebrafish, the Crumbs-Notch pathway is important for restriction of mitosis to apical surface and also in the maintenance of neuroepithelial polarity. Crumbs proteins were shown to directly interact with the extracellular domain of Notch and inhibit its activity (Ohata et al., 2011) . These studies suggest that the interaction between Notch signalling cascade and Crumbs is evolutionarily conserved and that Crumbs is part of a negative feedback loop during Notch signalling. Based on this it can be predicted that the conditional removal of CRB2 would lead to ectopic activation of Notch signalling. Interestingly, the phenotype observed in Notch1, Hes1 and Hes5 loss of function mutant brains is remarkably similar to that of Crb2 cKO phenotype, which is the loss of progenitor pools and precocious neural differentiation (Ohtsuka et al., 1999; Yoon and Gaiano, 2005; Mizutani et al., 2007; Pellissier et al., 2013) . In the developing brain, CRB2 and Notch may positively regulate each other and CRB2 could directly bind to extracellular domain of Notch and sequester progenitor cells from neural differentiation signals. Overall, the above-proposed mechanisms are not mutually exclusive and CRB2 may act via the concerted action of several interacting proteins and interplay of signaling pathways.
